Authors
Loading...
Computational analysis reveals restricted molecular shape diversity across commercial drugs, suggesting narrow exploration of chemical space.
Bemis et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: